Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|March 13, 2019
Radiopharmaceuticals for Relapsed or Refractory LeukemiasCharles A Kunos, Jacek Capala, Susan Percy Ivy
Frontiers in Oncology|July 19, 2019
Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master FilesCharles A Kunos, Jacek Capala, Susan Percy Ivy
Frontiers in Oncology|July 13, 2019
Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix CancerCharles A Kunos, Jacek Capala, Elise C Kohn, et al.
Frontiers in Oncology|April 16, 2019
Radiopharmaceuticals for Relapsed or Refractory Ovarian CancersCharles A Kunos, Jacek Capala, Shanda Finnigan, et al.
Frontiers in Oncology|April 20, 2017
Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor CancersCharles A Kunos, Edward Chu, Della Makower, et al.
Frontiers in Oncology|October 26, 2019
Clinical Outcome Assessments Toolbox for RadiopharmaceuticalsCharles A Kunos, Jacek Capala, Adam P Dicker, et al.
Cancer|January 30, 2014
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061Michelle A Rudek, Page C Moore, Ronald T Mitsuyasu, et al.
Cancer|April 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumorsMeghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, et al.
The Lancet. Oncology|September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium studyKeith C Bible, Vera J Suman, Julian R Molina, et al.
Cancer|April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumorsDavid S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
Pageof 1